de Morgan Stanley Acadia Pharmaceuticals ACAD Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 23.9 M | Vender |
946,639
-146,512
| -13% | -USD 3.22 M | ﹤0.01% | 2938 |
|
|
2026
Q1 | USD 24.3 M | Vender |
1,093,151
-48,823
| -4% | -USD 1.17 M | ﹤0.01% | 2773 |
|
|
2025
Q4 | USD 30.5 M | Vender |
1,141,974
-46,432
| -4% | -USD 1.11 M | ﹤0.01% | 2550 |
|
|
2025
Q3 | USD 25.4 M | Vender |
1,188,406
-2,922,841
| -71% | -USD 69.1 M | ﹤0.01% | 2663 |
|
|
2025
Q2 | USD 88.7 M | Vender |
4,111,247
-568,936
| -12% | -USD 10.6 M | 0.01% | 1418 |
|
|
2025
Q1 | USD 77.7 M | Vender |
4,680,183
-2,616,866
| -36% | -USD 47.5 M | 0.01% | 1431 |
|
|
2024
Q4 | USD 134 M | Comprar |
7,297,049
+5,621,195
| +335% | +USD 90.7 M | 0.01% | 1056 |
|
|
2024
Q3 | USD 25.8 M | Vender |
1,675,854
-715,251
| -30% | -USD 11.9 M | ﹤0.01% | 2527 |
|
|
2024
Q2 | USD 38.9 M | Comprar |
2,391,105
+928,093
| +63% | +USD 15 M | ﹤0.01% | 1983 |
|
|
2024
Q1 | USD 27.1 M | Comprar |
1,463,012
+101,112
| +7% | +USD 2.51 M | ﹤0.01% | 2361 |
|
|
2023
Q4 | USD 42.6 M | Vender |
1,361,900
-494,480
| -27% | -USD 11.8 M | ﹤0.01% | 1898 |
|
|
2023
Q3 | USD 38.7 M | Vender |
1,856,380
-1,871,600
| -50% | -USD 50.8 M | ﹤0.01% | 1818 |
|
|
2023
Q2 | USD 89.3 M | Vender |
3,727,980
-186,724
| -5% | -USD 4.15 M | 0.01% | 1163 |
|
|
2023
Q1 | USD 73.7 M | Comprar |
3,914,704
+1,169,966
| +43% | +USD 22.3 M | 0.01% | 1249 |
|
|
2022
Q4 | USD 43.7 M | Vender |
2,744,738
-326,375
| -11% | -USD 5.1 M | 0.01% | 1616 |
|
|
2022
Q3 | USD 50.2 M | Vender |
3,071,113
-48,959
| -2% | -USD 793 k | 0.01% | 1311 |
|
|
2022
Q2 | USD 44 M | Comprar |
3,120,072
+2,179,690
| +232% | +USD 40.7 M | 0.01% | 1478 |
|
|
2022
Q1 | USD 22.8 M | Comprar |
940,382
+277,723
| +42% | +USD 6.72 M | ﹤0.01% | 1980 |
|
|
2021
Q4 | USD 15.5 M | Vender |
662,659
-158,584
| -19% | -USD 3.19 M | ﹤0.01% | 2444 |
|
|
2021
Q3 | USD 13.6 M | Vender |
821,243
-14,409
| -2% | -USD 278 k | ﹤0.01% | 2544 |
|
|
2021
Q2 | USD 20.4 M | Comprar |
835,652
+192,602
| +30% | +USD 4.35 M | ﹤0.01% | 2125 |
|
|
2021
Q1 | USD 16.6 M | Comprar |
643,050
+133,567
| +26% | +USD 5.88 M | ﹤0.01% | 2112 |
|
|
2020
Q4 | USD 27.2 M | Comprar |
509,483
+23,844
| +5% | +USD 1.18 M | ﹤0.01% | 1539 |
|
|
2020
Q3 | USD 20 M | Comprar |
485,639
+311,707
| +179% | +USD 13.5 M | ﹤0.01% | 1487 |
|
|
2020
Q2 | USD 8.43 M | Vender |
173,932
-7,512
| -4% | -USD 361 k | ﹤0.01% | 2124 |
|
|
2020
Q1 | USD 7.66 M | Vender |
181,444
-360,203
| -67% | -USD 14.8 M | ﹤0.01% | 2020 |
|
|
2019
Q4 | USD 23.2 M | Comprar |
541,647
+235,766
| +77% | +USD 10.3 M | 0.01% | 1535 |
|
|
2019
Q3 | USD 11 M | Comprar |
305,881
+164,360
| +116% | +USD 4.98 M | ﹤0.01% | 2020 |
|
|
2019
Q2 | USD 3.78 M | Vender |
141,521
-21,314
| -13% | -USD 544 k | ﹤0.01% | 3215 |
|
|
2019
Q1 | USD 4.37 M | Vender |
162,835
-105,706
| -39% | -USD 2.47 M | ﹤0.01% | 2839 |
|
|
2018
Q4 | USD 4.34 M | Comprar |
268,541
+8,286
| +3% | +USD 161 k | ﹤0.01% | 3059 |
|
|
2018
Q3 | USD 5.4 M | Vender |
260,255
-677,452
| -72% | -USD 10.7 M | ﹤0.01% | 3102 |
|
|
2018
Q2 | USD 14.3 M | Comprar |
937,707
+480,227
| +105% | +USD 8.56 M | ﹤0.01% | 1979 |
|
|
2018
Q1 | USD 10.3 M | Vender |
457,480
-441,234
| -49% | -USD 12.2 M | ﹤0.01% | 2313 |
|
|
2017
Q4 | USD 27.1 M | Comprar |
898,714
+535,322
| +147% | +USD 17.1 M | 0.01% | 1411 |
|
|
2017
Q3 | USD 13.7 M | Comprar |
363,392
+146,433
| +67% | +USD 4.76 M | ﹤0.01% | 1958 |
|
|
2017
Q2 | USD 6.05 M | Comprar |
216,959
+27,712
| +15% | +USD 826 k | ﹤0.01% | 2656 |
|
|
2017
Q1 | USD 6.51 M | Vender |
189,247
-2,737
| -1% | -USD 96.6 k | ﹤0.01% | 2598 |
|
|
2016
Q4 | USD 5.54 M | Vender |
191,984
-25,696
| -12% | -USD 680 k | ﹤0.01% | 2883 |
|
|
2016
Q3 | USD 6.92 M | Comprar |
217,680
+51,940
| +31% | +USD 1.76 M | ﹤0.01% | 2350 |
|
|
2016
Q2 | USD 5.38 M | Vender |
165,740
-88,558
| -35% | -USD 2.96 M | ﹤0.01% | 2546 |
|
|
2016
Q1 | USD 7.11 M | Vender |
254,298
-66,885
| -21% | -USD 1.46 M | ﹤0.01% | 2178 |
|
|
2015
Q4 | USD 11.4 M | Comprar |
321,183
+27,260
| +9% | +USD 960 k | ﹤0.01% | 1856 |
|
|
2015
Q3 | USD 9.7 M | Comprar |
293,923
+29,866
| +11% | +USD 1.24 M | ﹤0.01% | 1980 |
|
|
2015
Q2 | USD 11.1 M | Vender |
264,057
-26,236
| -9% | -USD 1.02 M | ﹤0.01% | 2013 |
|
|
2015
Q1 | USD 9.46 M | Vender |
290,293
-222,042
| -43% | -USD 7.63 M | ﹤0.01% | 2106 |
|
|
2014
Q4 | USD 16.3 M | Comprar |
512,335
+402,914
| +368% | +USD 11.4 M | 0.01% | 1631 |
|
|
2014
Q3 | USD 2.71 M | Comprar |
109,421
+30,531
| +39% | +USD 714 k | ﹤0.01% | 3186 |
|
|
2014
Q2 | USD 1.78 M | Vender |
78,890
-79,033
| -50% | -USD 1.65 M | ﹤0.01% | 3571 |
|
|
2014
Q1 | USD 3.84 M | Comprar |
157,923
+61,395
| +64% | +USD 1.55 M | ﹤0.01% | 2825 |
|
|
2013
Q4 | USD 2.41 M | Vender |
96,528
-72,778
| -43% | -USD 1.72 M | ﹤0.01% | 3247 |
|
|
2013
Q3 | USD 4.65 M | Comprar |
169,306
+77,575
| +85% | +USD 1.62 M | ﹤0.01% | 2492 |
|
|
2013
Q2 | USD 1.66 M | Comprar |
+91,731
| Nuevas | +USD 1.26 M | ﹤0.01% | 3305 |
|
Otros fondos que tienen ACAD en su cartera
BBA
Posición de Morgan Stanley en ACAD: resumen de T2 2026
Morgan Stanley redujo su participación en Acadia Pharmaceuticals (ACAD) en 13% durante T2 2026, al vender acciones por un valor estimado de USD 3.22 M, y conservó 946,639 acciones valuadas en USD 23.9 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #2938.
Morgan Stanley reportó por primera vez una posición en ACAD en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 134 M en T4 2024. Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank mantienen una posición en ACAD.
- Al cierre de T2 2026, Morgan Stanley tenía 946,639 acciones de Acadia Pharmaceuticals con un valor de USD 23.9 M.
- Morgan Stanley vendió 146,512 acciones de Acadia Pharmaceuticals en T2 2026, por un valor estimado de USD 3.22 M.
- Acadia Pharmaceuticals representó ﹤0.01% de la cartera de Morgan Stanley en T2 2026 y fue su posición número 2938.
- Morgan Stanley reportó por primera vez una posición en Acadia Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Morgan Stanley en Acadia Pharmaceuticals alcanzó su máximo de USD 134 M en T4 2024.
- Al cierre de T2 2026, 354 fondos que sigue Wall St. Rank tenían Acadia Pharmaceuticals en cartera.
Según el Informe 13F de Morgan Stanley correspondiente a T2 2026, presentado el 13 ago 2026.